NASDAQ:RCM

R1 RCM (RCM) Stock Forecast, Price & News

$15.58

+0.50 (+3.32%)

(As of 09/22/2023 ET)

Compare

Today's Range: $14.98
▼
$15.75
50-Day Range: $15.08
▼
$18.49
52-Week Range: $6.71
▼
$19.46

Volume: 1.64 million shs
Average Volume: 2.52 million shs
Market Capitalization: $6.53 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $19.11

R1 RCM MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.88 Rating Score
Upside/Downside: 22.6% Upside
$19.11 Price Target
Short Interest: Healthy
7.89% of Float Sold Short
Dividend Strength: N/A
Sustainability: -1.33
Upright™ Environmental Score
News Sentiment: 0.75
Based on 5 Articles This Week
Insider Trading: Selling Shares
$858,500 Sold Last Quarter
Proj. Earnings Growth: 262.50%
From $0.08 to $0.29 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.75 out of 5 stars

Business Services Sector

58th out of 307 stocks

Management Services Industry

3rd out of 6 stocks

3.4

Analyst's Opinion

Consensus Rating
R1 RCM has received a consensus rating of Moderate Buy. The company's average rating score is 2.88, and is based on 14 buy ratings, 2 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $19.11, R1 RCM has a forecasted upside of 22.6% from its current price of $15.58.
Amount of Analyst Coverage
R1 RCM has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

3.0

Short Interest

Percentage of Shares Shorted
7.89% of the float of R1 RCM has been sold short.
Short Interest Ratio / Days to Cover
R1 RCM has a short interest ratio ("days to cover") of 6.4.
Change versus previous month
Short interest in R1 RCM has recently decreased by 6.77%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
R1 RCM does not currently pay a dividend.
Dividend Growth
R1 RCM does not have a long track record of dividend growth.

3.6

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
R1 RCM has received a 45.11% net impact score from Upright. R1 Rcm seems to create the most significant positive value in categories "Jobs", "Taxes", and "Physical diseases". The positive contribution in the "Physical diseases" impact category is mostly driven by its "Documentation software for clinicians", "Personal health record software", and "Hospital cost management software" products. See details.
Environmental Sustainability
The Environmental Impact score for R1 RCM is -1.33.

2.6

News and Social Media Coverage

News Sentiment
R1 RCM has a news sentiment score of 0.75. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Business Services companies.
News Coverage This Week
MarketBeat has tracked 5 news articles for R1 RCM this week, compared to 4 articles on an average week.
MarketBeat Follows
Only 1 people have added R1 RCM to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

4.2

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, R1 RCM insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $858,500.00 in company stock.
Percentage Held by Insiders
37.00% of the stock of R1 RCM is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
61.10% of the stock of R1 RCM is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.9

Earnings and Valuation

Earnings Growth
Earnings for R1 RCM are expected to grow by 262.50% in the coming year, from $0.08 to $0.29 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of R1 RCM is -97.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of R1 RCM is -97.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
R1 RCM has a P/B Ratio of 2.39. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About R1 RCM (NASDAQ:RCM) Stock

R1 RCM Inc. provides technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and physician groups. It offers end-to-end revenue cycle management (RCM) services, which address the spectrum of revenue cycle challenges faced by healthcare providers. The company provides modular services, including physician advisory services, which assists healthcare organizations in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes; practice management services that offers administrative and operational support for patient care and outsource non-core functions; revenue integrity solutions, including coding management services, such as business intelligence and analysis, human capital management, accountability framework, and quality management programs; patient experience; and business office services. R1 RCM Inc. was founded in 2003 and is headquartered in Murray, Utah.

RCM Price History

30 days | 90 days | 365 days | Advanced Chart

RCM Stock News Headlines

September 20, 2023 | finance.yahoo.com

R1 RCM Inc. sees growth despite trading at discount

September 18, 2023 | finance.yahoo.com

Returns On Capital Are Showing Encouraging Signs At R1 RCM (NASDAQ:RCM)

September 22, 2023 | Behind the Markets (Ad)

66,000% upside on tiny biotech?

The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.

September 12, 2023 | finance.yahoo.com

Implied Volatility Surging for R1 RCM (RCM) Stock Options

August 27, 2023 | msn.com

R1 RCM: Attractively Priced, Capital Produces $0.90/Share In Earnings, Reiterate Buy

August 20, 2023 | finance.yahoo.com

One R1 RCM Insider Raised Their Stake In The Previous Year

August 15, 2023 | msn.com

Cantor Fitzgerald Initiates Coverage of R1 RCM (RCM) with Overweight Recommendation

August 15, 2023 | markets.businessinsider.com

R1 RCM's Robust Client Base And $1.2 Trillion Potential: The Growth Forecast By Analyst

September 22, 2023 | Behind the Markets (Ad)

66,000% upside on tiny biotech?

August 7, 2023 | markets.businessinsider.com

Truist Financial Sticks to Its Hold Rating for R1 RCM (RCM)

August 5, 2023 | markets.businessinsider.com

RBC Capital Reaffirms Their Buy Rating on R1 RCM (RCM)

August 4, 2023 | markets.businessinsider.com

Robert W. Baird Keeps Their Buy Rating on R1 RCM (RCM)

August 3, 2023 | msn.com

Barclays Maintains R1 RCM (RCM) Overweight Recommendation

August 2, 2023 | finance.yahoo.com

R1 RCM Inc. (RCM) Reports Break-Even Earnings for Q2

August 2, 2023 | finance.yahoo.com

Compared to Estimates, R1 RCM Inc. (RCM) Q2 Earnings: A Look at Key Metrics

August 2, 2023 | seekingalpha.com

R1 RCM Inc. 2023 Q2 - Results - Earnings Call Presentation

August 2, 2023 | finanznachrichten.de

R1 RCM Inc.: R1 RCM Reports Second Quarter 2023 Results

August 2, 2023 | finance.yahoo.com

R1 RCM Reports Second Quarter 2023 Results

August 1, 2023 | seekingalpha.com

R1 RCM Q2 2023 Earnings Preview

July 21, 2023 | msn.com

Guggenheim Reiterates R1 RCM (RCM) Buy Recommendation

July 21, 2023 | markets.businessinsider.com

6 Analysts Have This to Say About R1 RCM

July 19, 2023 | markets.businessinsider.com

Truist Financial Keeps Their Hold Rating on R1 RCM (RCM)

July 14, 2023 | finance.yahoo.com

Positive week for R1 RCM Inc. (NASDAQ:RCM) institutional investors who lost 23% over the past year

July 12, 2023 | finance.yahoo.com

R1 RCM to Release Second Quarter 2023 Results on August 2

June 22, 2023 | marketwatch.com

Medical Billing Outsourcing Services Market Overview 2023 to 2030, Future Trends and Forecast | R1 RCM, Cerner, Allscripts

June 20, 2023 | markets.businessinsider.com

Bank of America Securities Remains a Buy on R1 RCM (RCM)

June 14, 2023 | msn.com

R1 RCM: Value Proposition Is Only More Attractive Now

See More Headlines

Receive RCM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for R1 RCM and its competitors with MarketBeat's FREE daily newsletter.

RCM Company Calendar

Last Earnings: 2/16/2023
Today: 9/22/2023
Next Earnings (Estimated): 11/14/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Management services
Sub-Industry: Health Care Services
Sector: Business Services
Current Symbol: NASDAQ:RCM
Previous Symbol: NYSE:RCM
CUSIP: 00438V10
CIK: 1472595
Web: www.r1rcm.com
Phone: (312) 324-7820
Fax: 302-655-5049
Employees: 27,800
Year Founded: 2003

Price Target and Rating

Average Stock Price Forecast: $19.11
High Stock Price Forecast: $25.00
Low Stock Price Forecast: $10.00
Forecasted Upside/Downside: +22.6%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.88
Research Coverage: 16 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.16)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 194.75
P/E Growth: N/A
Net Income: $-57,600,000.00
Net Margins: -3.09%
Pretax Margin: -2.82%
Return on Equity: -2.41%
Return on Assets: -1.30%

Debt

Debt-to-Equity Ratio: 0.62
Current Ratio: 1.80
Quick Ratio: 1.80

Sales & Book Value

Annual Sales: $1.81 billion
Price / Sales: 3.61
Cash Flow: $0.28 per share
Price / Cash Flow: 55.74
Book Value: $6.53 per share
Price / Book: 2.39

Miscellaneous

Outstanding Shares: 418,960,000
Free Float: 263,944,000
Market Cap: $6.53 billion
Optionable: Not Optionable
Beta: 0.84

Social Links

7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

Mr. Lee Rivas (Age 48)
CEO & Director
Comp: $1.12M

Mr. John M. Sparby (Age 47)
Pres
Comp: $656.99k

Ms. Jennifer Williams (Age 46)
Exec. VP, CFO & Treasurer

Mr. Richard B. Evans Jr. (Age 55)
Sr. VP, Corp. Controller & Chief Accounting Officer

Mr. Atif A. Rahim
Sr. VP of Investor Relations & Bus. Devel.

Mr. Corey Perman
Exec. VP of Compliance & Risk

Mr. Sean Radcliffe
Exec. VP, Gen. Counsel & Corp. Sec.

Ms. Kate Sanderson
Exec. VP & Chief HR Officer

Mr. David Strickle
Exec. VP of Integration

Mr. Kyle A. Hicok (Age 43)
Exec. VP & Chief Commercial Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

RCM Stock - Frequently Asked Questions

Should I buy or sell R1 RCM stock right now?: 16 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for R1 RCM in the last twelve months. There are currently 2 hold ratings and 14 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" RCM shares.
View RCM analyst ratings or view top-rated stocks.
What is R1 RCM's stock price forecast for 2023?: 16 Wall Street analysts have issued 12-month price targets for R1 RCM's shares. Their RCM share price forecasts range from $10.00 to $25.00. On average, they anticipate the company's stock price to reach $19.11 in the next year. This suggests a possible upside of 22.6% from the stock's current price.
View analysts price targets for RCM or view top-rated stocks among Wall Street analysts.
How have RCM shares performed in 2023?: R1 RCM's stock was trading at $10.95 at the start of the year. Since then, RCM stock has increased by 42.3% and is now trading at $15.58.
View the best growth stocks for 2023 here.
When is R1 RCM's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 14th 2023.
View our RCM earnings forecast.
How were R1 RCM's earnings last quarter?: R1 RCM Inc. (NASDAQ:RCM) announced its quarterly earnings results on Thursday, February, 16th. The healthcare provider reported ($0.09) earnings per share for the quarter, missing the consensus estimate of ($0.03) by $0.06. The healthcare provider had revenue of $532.80 million for the quarter, compared to the consensus estimate of $519.28 million. R1 RCM had a negative net margin of 3.09% and a negative trailing twelve-month return on equity of 2.41%. The company's quarterly revenue was up 33.6% on a year-over-year basis. During the same period last year, the firm earned $0.11 EPS.
What ETFs hold R1 RCM's stock?: ETFs with the largest weight of R1 RCM (NASDAQ:RCM) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), Thrivent Small-Mid Cap ESG ETF (TSME), Fidelity Digital Health ETF (FDHT), SPDR S&P Health Care Services ETF (XHS) and iShares U.S. Healthcare Providers ETF (IHF).Invesco NASDAQ Next Gen 100 ETF (QQQJ).
What guidance has R1 RCM issued on next quarter's earnings?: R1 RCM issued an update on its FY 2023 earnings guidance on Wednesday, August, 2nd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $2.25 billion-$2.27 billion, compared to the consensus revenue estimate of $2.31 billion.
What is Joseph Flanagan's approval rating as R1 RCM's CEO?: 253 employees have rated R1 RCM Chief Executive Officer Joseph Flanagan on Glassdoor.com. Joseph Flanagan has an approval rating of 70% among the company's employees.

What other stocks do shareholders of R1 RCM own?: Based on aggregate information from My MarketBeat watchlists, some companies that other R1 RCM investors own include NVIDIA (NVDA), JD.com (JD), Baozun (BZUN), Inseego (INSG), BioXcel Therapeutics (BTAI), Marvell Technology (MRVL), Akoustis Technologies (AKTS), Alibaba Group (BABA), Bilibili (BILI) and Model N (MODN).
What is R1 RCM's stock symbol?: R1 RCM trades on the NASDAQ under the ticker symbol "RCM."
Who are R1 RCM's major shareholders?: R1 RCM's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (3.36%), Capital International Investors (1.96%), Bank of New York Mellon Corp (1.62%), Polar Capital Holdings Plc (1.12%), Snyder Capital Management L P (0.99%) and State Street Corp (0.98%). Insiders that own company stock include Achi Series Lllp Tcp-Asc, Alex Mandl, Gary Steven Long, John B Henneman III, John M Sparby, Joseph Gerard Flanagan, Lee Rivas and Richard B Jr Evans.
View institutional ownership trends.
How do I buy shares of R1 RCM?: Shares of RCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is R1 RCM's stock price today?: One share of RCM stock can currently be purchased for approximately $15.58.
How much money does R1 RCM make?: R1 RCM (NASDAQ:RCM) has a market capitalization of $6.53 billion and generates $1.81 billion in revenue each year. The healthcare provider earns $-57,600,000.00 in net income (profit) each year or ($0.16) on an earnings per share basis.
How many employees does R1 RCM have?: The company employs 27,800 workers across the globe.
Does R1 RCM have any subsidiaries?: The following companies are subsidiares of R1 RCM: Accretive Health Mauritius Inc., Cerner RevWorks, Clearsight Intermediate Holdings Inc., Cloudmed, Flare Capital Partners Investment Company, Intermedix, Intermedix ARM LLC, Intermedix Corporation, Intermedix Holdings Inc., Intermedix Lietuva UAB, Intermedix Midco Inc., Intermedix Office Based LLC, Intermedix Staffing Inc., Medical Consultants Inc., Practice Support Resources LLC, Project Links Parent Inc., Project Roadrunner Merger Sub Inc., Project Roadrunner Parent Inc., R1 RCM Global Private Limited, R1 RCM India Private Limited, Rover16 Inc., SCHEDULING.COM INC., SCI Solutions, Tonic Health LLC, VisitPay, cGate Health Inc., and iVinci Partners LLC.
Read More
How can I contact R1 RCM?: R1 RCM's mailing address is 401 NORTH MICHIGAN AVENUE SUITE 2700, CHICAGO IL, 60611. The official website for the company is www.r1rcm.com. The healthcare provider can be reached via phone at (312) 324-7820, via email at arahim@r1rcm.com, or via fax at 302-655-5049.

This page (NASDAQ:RCM) was last updated on 9/22/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

R1 RCM (RCM) Stock Forecast, Price & News

R1 RCM MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability

News and Social Media Coverage

News Sentiment

News Coverage This Week

MarketBeat Follows

Company Ownership

Earnings and Valuation

About R1 RCM (NASDAQ:RCM) Stock

RCM Price History

RCM Stock News Headlines

RCM Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

Insiders & Institutions

RCM Stock - Frequently Asked Questions

Overall MarketRank^™